Literature DB >> 19291830

Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma.

Takayuki Kogure1, Yoshiyuki Ueno, Satoshi Sekiguchi, Kazuyuki Ishida, Takehiko Igarashi, Yuta Wakui, Takao Iwasaki, Tooru Shimosegawa.   

Abstract

A liver tumor 35 mm in diameter was found incidentally in a 40-year-old woman who had no history of liver diseases or the use of oral contraceptives. Radiological diagnostics showed the typical findings of liver cell adenoma (LCA). Dynamic computed tomography revealed that the tumor showed a homogenous enhancement in the arterial phase and almost the same enhancement as the surrounding liver parenchyma in the delayed phase. The tumor was found to contain fat on magnetic resonance imaging. A benign fat containing liver tumor was suggested. However, radiological findings altered, which caused us to suspect that a well-differentiated hepatocellular carcinoma (HCC) containing fat was becoming dedifferentiated. Partial hepatectomy was performed and the pathological findings showed the typical findings of LCA. This case was an extremely rare LCA, which had no background of risk for LCA and developed the sequential alteration of the radiological findings to suspect well-differentiated HCC.

Entities:  

Mesh:

Year:  2009        PMID: 19291830      PMCID: PMC2658857          DOI: 10.3748/wjg.15.1267

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Liver transplantation for treatment of giant hepatocellular adenomas.

Authors:  J Mueller; E B Keeffe; C O Esquivel
Journal:  Liver Transpl Surg       Date:  1995-03

2.  Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.

Authors:  S C Gordon; K R Reddy; A S Livingstone; L J Jeffers; E R Schiff
Journal:  Ann Intern Med       Date:  1986-10       Impact factor: 25.391

3.  Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.

Authors:  T Leese; O Farges; H Bismuth
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

4.  Oral contraceptives and cancer of the liver: a review with two additional cases.

Authors:  T S Helling; W G Wood
Journal:  Am J Gastroenterol       Date:  1982-07       Impact factor: 10.864

5.  Clomiphene citrate and liver-cell adenoma.

Authors:  D Carrasco; M Barrachina; M Prieto; J Berenguer
Journal:  N Engl J Med       Date:  1984-04-26       Impact factor: 91.245

6.  Hepatic adenomata and androgen treatment.

Authors:  D Carrasco; L Pallardo; M Prieto; J L Moll; J M Cruz; J Berenguer
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

7.  Hemorrhage caused by ruptured liver cell adenoma following long-term oral contraceptives: a case report.

Authors:  K Meissner
Journal:  Hepatogastroenterology       Date:  1998 Jan-Feb

8.  Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features.

Authors:  P Kerlin; G L Davis; D B McGill; L H Weiland; M A Adson; P F Sheedy
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

9.  Liver adenomatosis. An entity distinct from liver adenoma?

Authors:  J F Flejou; J Barge; Y Menu; C Degott; H Bismuth; F Potet; J P Benhamou
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

10.  Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature.

Authors:  A S Fink; H D Appelman; N W Thompson
Journal:  Surgery       Date:  1985-01       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.